Article

Piroxicam Loaded Solid Lipid Nanoparticles (SLNs): Potential for Topical Delivery

Harshita Krishnatreyya1★, Sanjay Dey2, Paulami Pal1, Pranab Jyoti Das1, Vipin Kumar Sharma3, Bhaskar Mazumder1★ Corresponding author

  1. 1Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, INDIA.
  2. 2Department of Pharmaceutics, School of Pharmacy, Techno India University, West Bengal, INDIA.
  3. 3Department of Pharmaceutical Sciences, Gurukul Kangri University, Haridwar, Uttarakhand, INDIA.

CORRESPONDENCE

Harshita Krishnatreyya

Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, INDIA.

harshita.krishnatreyya@gmail.com

Received: 13-09-2018; Revised: 28-12-2018; Accepted: 20-03-2019.

Volume 53, Issue 2S · pp. s82–s92 · PUBLISHED 2019 · DOI: 10.5530/ijper.53.2s.52

View on IJPER original site ↗

ABSTRACT

Aim: The objective of this study was to develop suitable lipid nanocarriers for topical delivery of Piroxicam, known for its anti-inflammatory and anti-arthritic properties and to increase its therapeutic potential and residence time at the site of inflammation and in systemic circulation. Materials and Methods: Piroxicam loaded Solid lipid nanoparticles (SLNs) were prepared by high-speed homogenization followed by ultrasonication technique. Physicochemical evaluation of SLNs involved particle size and zeta potential analysis, electron micrographic analysis, drug loading, entrapment and release studies. Drug excipient interactions were studied by Fourier transform infrared spectroscopy (FTIR) and Differential scanning calorimetry (DSC). Prepared nanoparticles were assimilated into a topical gel system and evaluated for viscosity, in vitro permeation properties and in vivo efficacy assessment by carrageenan induced rat paw edema study. Results: Evaluation of prepared SLNs revealed the particle size, drug loading, entrapment efficiency and in vitro release to significantly differ (p<0.05) with different lipid and surfactant concentrations present in formulations. SEM and TEM were useful aids in studying the morphology of the SLNs. FTIR and DSC revealed no likely interaction amongst the drug and/or any excipients. In vitro permeation and in vivo anti-inflammatory study of the SLN gel revealed it to be a sustained permeation system, maintaining drug concentration over an extended period of time and providing a better therapeutic potential on topical dermal application when compared with a free drug gel. Conclusion: Our results proved the suitability and capability of fabricated piroxicam loaded SLN gel system in treating arthritic pain and inflammation when delivered topically.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Krishnatreyya, H., Dey, S., Pal, P., Das, P. J., Sharma, V. K., & Mazumder, B. (2019). Piroxicam Loaded Solid Lipid Nanoparticles (SLNs): Potential for Topical Delivery. Indian Journal of Pharmaceutical Education and Research, 53(2S), s82–s92. https://doi.org/10.5530/ijper.53.2s.52